Correlation between gender and cytomorphonuclear characteristics in human melanomas and in vitro evidence of sex steroid-induced modifications in the morphonuclear characteristics of three human melanoma cell lines

Melanoma Research

Volumn 7, Issue 5, 1997, Pages 382-392

  Lorea P ^a   Decaestecker, C ^a   Goldschmidt, D ^b   Renard, N ^c   Andre J ^d   Lipski, D ^f   Van den Heule, B ^e   Salmon, I ^b   Darro, F ^a   Kiss, R ^a,g  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

^d Centre d'Anatomie Pathologique et de Cytologie   (Belgium)

^e Ctr Morphol Pathologique Prat l'A   (Belgium)

^f Centre Hospitalier de Dinant   (Belgium)

^g FNRS   (Belgium)

Author keywords

Chromatin pattern; Feulgen stain; Human melanoma; Image cytometry; Morphometry; Sex steroids

Indexed keywords

ANDROSTANOLONE; ESTRADIOL;

ARTICLE; CELL ULTRASTRUCTURE; CHROMATIN STRUCTURE; COMPUTER ASSISTED DIAGNOSIS; HORMONAL REGULATION; HUMAN; HUMAN CELL; MELANOMA; MORPHOMETRICS; PRIORITY JOURNAL;

EID: 9844231493     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199710000-00004     Document Type: Article

References (33)

1. Boyle P, Maisonneuve P, Doré J-F. Epidemiology of malignant melanoma. Br Med Bull 1995; 51: 523-547.
2. Thorn M, Ponten F, Bergstrom R, et al. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 761-769.
3. Houghton AN, Balch CM. Treatment for advanced melanoma. In: Balch CM, Houghton AN, Milton GW, et al., eds. Cutaneous Melanoma. Philadelphia: JB Lippincott, 1992: 468-448.
4. Jatoi I, Gore ME. Sex, pregnancy, hormones and melanoma. BMJ 1993; 307: 2-3.
5. Holly EA, Cress RD, Ahn DK, et al. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 1995; 141: 943-950.
6. Le MG, Cabanes PA, Desvignes V, et al. Oral contraceptive use and risk of cutaneous melanoma in a case-control study of French women. Cancer Causes Control 1992; 3: 199-205.
7. MacCarthy KS Jr, Wortman J, Stowers S, et al. Sex steroid receptor analysis in human melanoma. Cancer 1980; 46: 1463-1470.
8. Shaw HM, Milton GW, Farago G, et al. Endocrine influences in survival from malignant melanoma. Cancer 1978; 42: 669-677.
9. Shaw HM, McGovern VJ, Milton GW; et al. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer 1980; 46: 2731-2735.
10. Rampen FHJ, Mulder JH. Malignant melanoma: an androgen-dependent tumor? Lancet 1980; i: 562-565.
11. Travers RL, Sober, AJ, Berwick M, et al. Increased thickness of pregnancy-associated melanoma. Br J Dermatol 1995; 132: 876-883.
12. MacKie RM, Bufalino R, Morabito A, et al. Lack of effect of pregnancy on outcome of melanoma. Lancet 1991; 337: 653-655.
13. Piantelli M, Maggiano N, Ricci R, et al. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Invest Dermatol 1995; 105: 248-253
14. Rümke P, Kleeberg ER, McKie RM, et al. Tamoxifen as a single agent for advanced melanoma in postmeno-pausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group. Melanoma Res 1992; 2: 153-156.
15. Cocconi G, Bella M, Calabresi F, et al. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med 1992; 327: 516-523.
16. Larsimont D, Kiss R., d'Olne D, et al. Correlation between cytomorphometric parameters and estrogen receptor levels in breast cancer. Cancer 1989; 63: 2162-2168.
17. de Launoit Y, Kiss R. In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by amino-gluthetimide. J Cancer Res Clin Oncol 1989; 115: 129-138.
18. Kiss R, Salmon I, Camby I, et al. Characterization of factors in routine loboratory protocols that significantly influence the Feugen reaction. J Histochem Cytochem 1993; 41: 935-945.
19. Kiss R, Gasperin P, Verhest A, et al. Modification of the tumor ploidy level via the choice of tissue taken as diploid reference in the digital cell image analysis of Feulgen-stained nuclei. Modern Pathol 1992; 5: 655-660.
20. Decaestecker C, Salmon I, Camby I, et al. Identification of high- versus lower-risk clinical sub-groups in the group of adult patients with supratentorial anaplasic astrocytomas. J Neuropathol Exp Neurol 1995; 54: 371-384.
21. Johnson RA, Wicheren DW. Applied Multivariate Statistical Analysis. Englewood Cliffs, New Jersey: Prentice-Hall International Editions, 1992.
22. Proctor JW, Auclair BG, Stokowski L. Endocrine factors and the growth and spread of B16 melanoma. J Natl Cancer Inst 1976; 57: 1197-1198.
23. Ladányi A, Tímmár J, Bocsi J, et al. Sex-dependent liver metastasis of human melanoma lines in SCID mice. Melanoma Res 1995; 5: 83-86.
24. Schleicher RL, Hitselberger MH, Beattie CW Inhibition of hamster melanoma growth by estrogen. Cancer Res 1987; 47: 453-459.
25. Walker MJ, Chaudhuri PK, Das Gupta TK, et al. Influence of host sex on the growth of human melanoma. Proc Soc Exp Biol Med 1980; 165: 96-99.
26. Feucht KA, Walker MJ, Das Gupta TK, et al. Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and athymic mice. Cancer Res 1988; 48: 7093-7101.
27. Darro F, Kruczynski A, Etievant C, et al. Monitoring of morphonuclear characteristics of hormone-sensitive and insensitive HCT-15 and LOVO human colorectal cells by means of digital cell image analysis. Anti-cancer Res 1993; 13: 512-522.
28. Duncan LM, Robin L, Travers RL, et al. Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: absence of immunohistochemically detectable hormone receptors. Human Pathol 1994; 25: 36-41.
29. Walker MJ, Ronan SG, Man MC, et al. Interrelationship between histopathologic characteristics of melanoma and estrogen receptor status. Cancer 1991; 68: 184-188.
30. Sawaya ME, Garland LD, Rothe MJ, et al. Oestrogen and progesterone receptors in lentigo maligna. Br J Dermatol 1988; 118: 69-71.
31. Lecavalier MA, From L, Gaid N. Absence of estrogen receptors in dysplastic nevi and malignant melanoma. J Am Acad Dermatol 1990; 23: 242-246.
32. Flowers JL, Seigler HF, McCarthy KS Sr, et al. Absence of estrogen receptors in human melanoma as evalu ated by a monoclonal antiestrogen receptor antibody. Arch Dermatol 1987; 123: 764-765.
33. Syne JS, Markaverich BM, Clark JH, et al. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites. Cancer Res 1982; 42: 4449-4454.